Search

Home > New FDA Approvals > 078 - Avycaz for pneumonia; IMG-7289 for myeloid malignancies; FDA flu season update
Podcast: New FDA Approvals
Episode:

078 - Avycaz for pneumonia; IMG-7289 for myeloid malignancies; FDA flu season update
Category: Science & Medicine
Duration: 00:07:27
Publish Date: 2018-02-02 07:00:00
Description:

February 2, 2018

check out the podcast website with a search function and all the links: newfdaapprovals.com 0:40 FDA approves Allergan's Avycaz for two types of pneumonia https://www.reuters.com/article/allergan-fda/fda-approves-allergans-avycaz-for-two-types-of-pneumonia-idUSL4N1PR5H9

https://www.prnewswire.com/news-releases/fda-approves-avycaz-ceftazidime-and-avibactam-for-the-treatment-of-patients-with-hospital-acquired-bacterial-pneumonia-and-ventilator-associated-bacterial-pneumonia-300592264.html

2:16 FDA approves Imago BioSciences’ IND application for treating myeloid malignancies https://www.prnewswire.com/news-releases/imago-biosciences-receives-fda-approval-of-ind-application-for-the-treatment-of-myeloid-malignancies-300591713.html

3:57 Statement from FDA Commissioner Scott Gottlieb, M.D., on ongoing efforts to mitigate impact of saline shortages during this flu season https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm595020.htm 

Nascent Medical, medical writing nascentmc.com Info@nascentmc.com
Total Play: 0